HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Grant S Schulert Selected Research

Cystic Fibrosis (Mucoviscidosis)

11/2004Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Grant S Schulert Research Topics

Disease

14Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2022 - 09/2014
13Macrophage Activation Syndrome
01/2022 - 04/2014
6Cytokine Release Syndrome
01/2021 - 04/2014
3Communicable Diseases (Infectious Diseases)
01/2022 - 11/2020
3COVID-19
12/2021 - 08/2020
3Inflammation (Inflammations)
01/2021 - 01/2019
3Infections
04/2009 - 11/2004
2Lung Diseases (Lung Disease)
01/2022 - 07/2020
2Arthritis (Polyarthritis)
01/2019 - 09/2014
2Fever (Fevers)
02/2018 - 08/2015
1Eosinophilia
01/2022
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
08/2021
1COVID-19 related pediatric multisystem inflammatory disease
08/2021
1Pain (Aches)
01/2021
1Hepatitis
07/2020
1Seizures (Absence Seizure)
02/2018
1Epilepsy (Aura)
02/2018
1Drug Resistant Epilepsy
02/2018
1Adult-Onset Still's Disease
01/2018
1Rheumatic Diseases (Rheumatism)
01/2018
1Rheumatoid Arthritis
01/2016
1Liver Diseases (Liver Disease)
08/2015
1Pneumonia (Pneumonitis)
11/2014
1Cystic Fibrosis (Mucoviscidosis)
11/2004
1Healthcare-Associated Pneumonia
11/2004

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2014
5CytokinesIBA
01/2021 - 04/2014
4Interleukin-1 (Interleukin 1)IBA
07/2020 - 01/2015
4Interleukin-18 (Interleukin 18)IBA
02/2020 - 01/2015
3PerforinIBA
12/2021 - 08/2015
3Biological ProductsIBA
01/2021 - 01/2018
3MicroRNAs (MicroRNA)IBA
01/2019 - 01/2016
2InterferonsIBA
01/2022 - 01/2021
2canakinumabFDA Link
01/2021 - 02/2018
2Interleukin-6 (Interleukin 6)IBA
07/2020 - 01/2015
1ProteomeIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2021
1ABO Blood-Group SystemIBA
12/2021
1Antiviral Agents (Antivirals)IBA
12/2021
1S100 Proteins (S 100 Protein)IBA
08/2021
1S100A12 ProteinIBA
08/2021
1ChemokinesIBA
01/2021
1tocilizumab (atlizumab)FDA Link
08/2020
1Adenosine DeaminaseIBA
01/2020
1InflammasomesIBA
01/2020
1Hemoglobins (Hemoglobin)IBA
01/2019
1AlarminsIBA
02/2018
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2018
1Scavenger Receptors (Scavenger Receptor)IBA
01/2018
1Granzymes (Granzyme)IBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
11/2014
1Antinuclear AntibodiesIBA
09/2014
1Interleukin-1beta (Interleukin 1 beta)IBA
04/2009
1Interleukin-8 (Interleukin 8)IBA
04/2009
1laminaranIBA
09/2006
1LigandsIBA
09/2006
1Mannose ReceptorIBA
09/2006
1MannansIBA
09/2006
1Complement Receptors (Complement Receptor)IBA
09/2006
1dectin 1IBA
09/2006
1Proteins (Proteins, Gene)FDA Link
11/2004

Therapy/Procedure

5Therapeutics
07/2020 - 04/2014
3Critical Care (Surgical Intensive Care)
01/2022 - 11/2020
2Biological Therapy
11/2019 - 01/2018
1Injections
09/2014